Analysts Viewpoint DiaMedica Therapeutics Inc [NASDAQ: DMAC] Sees Increase in Stock Value Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Insiders Updates Understanding the Risks of Investing in DiaMedica Therapeutics Inc (DMAC) DiaMedica Therapeutics Inc’s filing revealed that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $5.4 million on Jul